DIVI S LABORATORIES LTD vs Parmax Pharma Ltd
A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and Parmax Pharma Ltd (PARMAXPHARMALTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs PARMAXPHARMALTD on 9 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
- − ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
- − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -14.3% over past five years.", "Promoter holding is low: 30.8%", "Debtor days have increased from 57.4 to 95.2 days."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.